Insulin Glargine
-
Biocon Biologics, Viatris launch Interchangeable SEMGLEE and Insulin Glargine injection
The injections will help control high blood sugar in adult and paediatric patients with type 1 diabetes and adults with…
Read More » -
Biocon, Mylan Win Patent Litigation against Sanofi for Insulin Glargine Device
Bengaluru: Biocon Ltd. won a U.S.court ruling that invalidated a Sanofi patent on the Insulin Glargine device, removing a key…
Read More »
